In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin
1992 • 217 citations
Pneumococcal bacteremia during Ciprofloxacin therapy for pneumococcal pneumonia
1989 • 77 citations
Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests
1989 • 18 citations
A comparison of antimicrobial activity of ofloxacin, l-ofloxacin, and other oral agents for respiratory pathogens
1992 • 17 citations
Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates
1995 • 14 citations
Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests
1993 • 10 citations
Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia
1989 • 8 citations
In Vitro and In Vivo Antibacterial Activities of Levofloxacin ( l -Ofloxacin), an Optically Active Ofloxacin
1992 • 4 citations